PSMA PET scan for prostate cancer recurrence
Part of Cancer, Kidney & urinary clinical trials.
This trial looks at how well a special PET scan (called PSMA PET) can find prostate cancer that has come back after treatment. It uses a radioactive tracer to spot cancer cells. Your doctor may already have ordered this scan as part of your regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must give your permission to join the study by signing a consent form.
- Your doctor must have ordered a PSMA PET scan for you as part of your regular care.
- The PSMA PET scan must have been done correctly without any technical problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether a special PET scan using 68Ga-PSMA-11 can detect prostate cancer that has returned after surgery or radiation, measured by rising PSA. If the scan works well, it may help doctors find where the cancer is coming back.
This trial looks at how well a special scan called PSMA PET/CT can help find the spread of prostate cancer when it is first diagnosed. You may be able to join if your doctor has already recommended this scan for you.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This trial uses a special PET scan (PSMA PET) to check if prostate cancer returns after focused treatment (focal therapy). It may help find any remaining cancer that standard scans miss.
This trial uses a special PET scan to detect prostate cancer when your PSA level is slightly rising after prostate removal surgery. It aims to find cancer early so treatment decisions can be better informed.
Hear when a new Biochemical Recurrence of Malignant Neoplasm of Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.